# Allergy and Infectious Diseases Research (93.855)

Source: https://welltoldgrants.com/programs/93-855-allergy-and-infectious-diseases-research/  
Publisher: Well Told Grants. Data: USAspending.gov and Grants.gov, updated November 7, 2026.

Allergy and Infectious Diseases Research is run by Department of Health and Human Services. From fiscal 2021 to 2025 it awarded $22 billion in 13,282 grants, about $1.6 million per award.

## Objectives

To assist public and private nonprofit institutions and individuals to establish, expand and improve biomedical research and research training in infectious diseases and related areas; to conduct developmental research, to produce and test research materials. To assist public, private and commercial institutions to conduct developmental research, to produce and test research materials, to provide research services as required by the agency for programs in infectious diseases, and controlling disease caused by infectious or parasitic agents, allergic and immunologic diseases and related areas. Projects range from studies of microbial physiology and antigenic structure to collaborative trials of experimental drugs and vaccines, mechanisms of resistance to antibiotics as well as research dealing with epidemiological observations in hospitalized patients or community populations and progress in allergic and immunologic diseases. Because of this dual focus, the program encompasses both basic research and clinical research. Small Business Innovation Research (SBIR) program expands and improves private sector participation in biomedical research. The SBIR Program intends to increase and facilitate private sector commercialization of innovations derived from Federal research and development; to increase small business participation in Federal research and development; and to foster and encourage participation of socially and economically disadvantaged small business concerns and women-owned small business concerns in technological innovation. The Small Business Technology Transfer (STTR) program stimulates and fosters scientific and technological innovation through cooperative research and development carried out between small business concerns and research institutions; to foster technology transfer between small business concerns and research institutions; to increase private sector commercialization of innovations derived from Federal research and development; and to foster and encourage participation of socially and economically disadvantaged small business concerns and women-owned small business concerns in technological innovation. Research Career Development Awards support the development of scientists during the formative stages of their careers. Individual National Research Service Awards (NRSAs) are made directly to approve applicants for research training in specified biomedical shortage areas. In addition, Institutional National Research Service Awards are made to enable institutions to select and make awards to individuals to receive training under the aegis of their institutional program.

## Funding by fiscal year

| Year | Amount | Awards |
|---|---|---|
| 2021 | $4.5 billion | 6,432 |
| 2022 | $4.9 billion | 6,345 |
| 2023 | $4.0 billion | 6,264 |
| 2024 | $4.1 billion | 6,371 |
| 2025 | $4.2 billion | 6,044 |

## Largest recipients

| Recipient | State | Amount |
|---|---|---|
| Fred Hutchinson Cancer Center | Washington | $938 million |
| Duke University | North Carolina | $781 million |
| University of California, Los Angeles | California | $745 million |
| The Johns Hopkins University | Maryland | $668 million |
| Emory University | Georgia | $650 million |
| The Regents of the University of California, San Francisco | California | $622 million |
| University of Washington | Washington | $469 million |
| The Washington University | Missouri | $459 million |
| The Scripps Research Institute | California | $427 million |
| University of North Carolina at Chapel Hill | North Carolina | $371 million |
| University of Pittsburgh - of the Commonwealth System of Higher Education | Pennsylvania | $360 million |
| The Trustees of the University of Pennsylvania | Pennsylvania | $353 million |
| University of Texas Medical Branch at Galveston | Texas | $320 million |
| The General Hospital Corporation | Massachusetts | $310 million |
| The Leland Stanford Junior University | California | $295 million |
| Vanderbilt University Medical Center | Tennessee | $281 million |
| Weill Medical College of Cornell University | New York | $279 million |
| Yale Univ | Connecticut | $275 million |
| Regents of the University of Minnesota | Minnesota | $268 million |
| Brigham & Womens Hospital Inc | Massachusetts | $266 million |

## Open opportunities

- [Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required)](https://welltoldgrants.com/grants/rfa-ai-27-002-infectious-diseases-clinical-trials-network-idctn-um1/), closes November 10, 2026
- [Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required)](https://welltoldgrants.com/grants/rfa-ai-27-005-clinical-research-network-on-antimicrobial-resistance-um1/), closes November 10, 2026
- [Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)](https://welltoldgrants.com/grants/par-25-370-ethical-legal-and-social-implications-elsi-small-research/), closes November 16, 2026
- [Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)](https://welltoldgrants.com/grants/par-25-369-ethical-legal-and-social-implications-elsi-exploratory/), closes November 18, 2026
- [Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)](https://welltoldgrants.com/grants/par-25-371-ethical-legal-and-social-implications-elsi-research-r01/), closes November 18, 2026
- [Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)](https://welltoldgrants.com/grants/par-25-379-intervention-research-to-improve-native-american-health-r01/), closes January 7, 2027
- [Immune Tolerance Network (UM1 Clinical Trial Required)](https://welltoldgrants.com/grants/rfa-ai-28-005-immune-tolerance-network-um1-clinical-trial-required/), closes January 29, 2027
- [Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/rfa-ai-28-012-translational-centers-using-microphysiological-systems-for/), closes January 29, 2027
- [NLM Institutional Grants for Research Training in Biomedical Informatics, Data Science, and AI (T15 Independent Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/rfa-lm-28-001-nlm-institutional-grants-for-research-training-in-biomedical/), closes February 11, 2027
- [Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/rfa-ai-28-024-accelerating-research-and-development-of-next-generation/), closes February 11, 2027
- [NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)](https://welltoldgrants.com/grants/pa-27-100-nih-cdc-and-fda-small-business-innovation-research/), closes April 5, 2027
- [NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)](https://welltoldgrants.com/grants/pa-27-102-nih-small-business-technology-transfer-grant-parent-sttr/), closes April 5, 2027
- [Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/pa-24-185-mentored-patient-oriented-research-career-development-award/), closes May 7, 2027
- [Mentored Quantitative Research Development Award (Parent K25 Independent Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/pa-24-191-mentored-quantitative-research-development-award-parent-k25/), closes May 7, 2027
- [Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/pa-24-176-mentored-research-scientist-development-award-parent-k01/), closes May 7, 2027
- [NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/pa-24-194-nih-pathway-to-independence-award-parent-k99-r00/), closes May 7, 2027
- [Midcareer Investigator Award in Patient-Oriented Research (Parent K24 Independent Clinical Trial Required)](https://welltoldgrants.com/grants/pa-24-187-midcareer-investigator-award-in-patient-oriented-research/), closes May 7, 2027
- [Midcareer Investigator Award in Patient-Oriented Research (Parent K24 Independent Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/pa-24-188-midcareer-investigator-award-in-patient-oriented-research/), closes May 7, 2027
- [Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/pa-24-182-mentored-clinical-scientist-research-career-development/), closes May 8, 2027
- [Centers for Structural Biology of HIV and Other Infectious Diseases (U54 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/rfa-ai-28-031-centers-for-structural-biology-of-hiv-and-other/), closes May 28, 2027
- [Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)](https://welltoldgrants.com/grants/pa-24-254-change-of-recipient-organization-type-7-parent-clinical/), closes July 12, 2027
- [Successor-in-Interest (Type 6 Parent Clinical Trial Optional)](https://welltoldgrants.com/grants/pa-24-253-successor-in-interest-type-6-parent-clinical-trial/), closes July 17, 2027
- [NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/pa-25-080-nih-support-for-conferences-and-scientific-meetings-parent/), closes September 7, 2027
- [Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional)](https://welltoldgrants.com/grants/par-25-296-limited-competition-clinical-and-translational-science/), closes October 19, 2027
- [Pilot Projects Investigating Understudied Proteins Associated with Rare Diseases (R03 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/par-25-122-pilot-projects-investigating-understudied-proteins/), closes November 16, 2027
- [Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/rfa-da-26-034-chemical-countermeasures-research-program-ccrp-initiative/), closes November 18, 2027
- [Catalyze: Product Definition for Small Molecules, Biologics and Combination Products - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed)](https://welltoldgrants.com/grants/rfa-hl-26-017-catalyze-product-definition-for-small-molecules-biologics/), closes December 23, 2027
- [Catalyze: Product Definition for Small Molecules, Biologics, and Combination Products - Preliminary Product/Lead Series Identification and Combination Product Prototype (R33 - Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/rfa-hl-26-018-catalyze-product-definition-for-small-molecules-biologics/), closes December 23, 2027
- [Limited Competition: CCRP Initiative: Promoting a Basic Understanding of Chemical Threats to Skin (R34 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/pa-25-093-limited-competition-ccrp-initiative-promoting-a-basic/), closes January 7, 2028
- [Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)](https://welltoldgrants.com/grants/par-25-144-dissemination-and-implementation-research-in-health-r01/), closes January 7, 2028
- [Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)](https://welltoldgrants.com/grants/par-25-143-dissemination-and-implementation-research-in-health-r21/), closes January 7, 2028
- [Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/par-25-134-academic-research-enhancement-award-area-for-undergraduate/), closes January 7, 2028
- [NIAID Career Transition Award (K22 Independent Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/par-25-251-niaid-career-transition-award-k22-independent-clinical-trial/), closes January 7, 2028
- [Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/par-25-298-research-enhancement-award-program-reap-for-health/), closes January 7, 2028
- [NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/pa-25-302-nih-small-research-grant-program-parent-r03-clinical/), closes January 7, 2028
- [NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/pa-25-304-nih-exploratory-developmental-research-project-grant-parent/), closes January 7, 2028
- [NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Required)](https://welltoldgrants.com/grants/pa-25-306-nih-exploratory-developmental-research-project-grant-parent/), closes January 7, 2028
- [NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/pa-25-301-nih-research-project-grant-parent-r01-clinical-trial/), closes January 7, 2028
- [NIH Research Project Grant (Parent R01 Clinical Trial Required)](https://welltoldgrants.com/grants/pa-25-305-nih-research-project-grant-parent-r01-clinical-trial/), closes January 7, 2028
- [Stimulating Access to Research in Residency (StARR) (R38 Independent Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/rfa-hl-26-012-stimulating-access-to-research-in-residency-starr-r38/), closes January 10, 2028
- [Expanding the Target Landscape by Drugging the Undruggable (R21 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/par-25-442-expanding-the-target-landscape-by-drugging-the-undruggable/), closes February 17, 2028
- [Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32)](https://welltoldgrants.com/grants/pa-25-168-ruth-l-kirschstein-national-research-service-award-nrsa/), closes May 4, 2028
- [Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (Parent F32)](https://welltoldgrants.com/grants/pa-25-423-ruth-l-kirschstein-national-research-service-award-nrsa/), closes May 7, 2028
- [Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions Without NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30)](https://welltoldgrants.com/grants/pa-25-425-ruth-l-kirschstein-national-research-service-award-nrsa/), closes May 7, 2028
- [Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions with NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30)](https://welltoldgrants.com/grants/pa-25-426-ruth-l-kirschstein-national-research-service-award-nrsa/), closes May 7, 2028
- [Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship (Parent F31)](https://welltoldgrants.com/grants/pa-25-422-ruth-l-kirschstein-national-research-service-award-nrsa/), closes May 7, 2028
- [INCLUDE Project: Exploratory/Developmental Research Awards for Down syndrome (R21 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/rfa-od-27-003-include-project-exploratory-developmental-research-awards/), closes June 15, 2028
- [INCLUDE Project: Transformative Research Awards for Down syndrome (R01 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/rfa-od-27-004-include-project-transformative-research-awards-for-down/), closes June 15, 2028
- [Shared Instrumentation Grant (SIG) Program (S10 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/par-27-022-shared-instrumentation-grant-sig-program-s10-clinical-trial/), closes July 1, 2028
- [Seed Instrumentation Support (SIS) Program (S10 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/par-27-021-seed-instrumentation-support-sis-program-s10-clinical-trial/), closes July 1, 2028
- [Lasker Clinical Research Scholar's Program (Si2/R00 Clinical Trial Optional)](https://welltoldgrants.com/grants/par-27-076-lasker-clinical-research-scholar-s-program-si2-r00/), closes July 7, 2028
- [Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/par-25-322-stephen-i-katz-early-stage-investigator-research-project/), closes August 25, 2028
- [Support for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/par-25-414-support-for-research-excellence-sure-award-r16-clinical/), closes September 7, 2028
- [Support for Research Excellence First Independent Research (SuRE-First) Award (R16 - Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/par-25-415-support-for-research-excellence-first-independent-research/), closes September 7, 2028
- [Development of Candidate Medical Countermeasures (MCMs) and Technologies Against Radiological/Nuclear or Chemical Threats (U01 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/rfa-ai-27-014-development-of-candidate-medical-countermeasures-mcms-and/), closes October 9, 2028
- [Limited Competition: Stimulating Access to Research in Residency Transition Scholar (StARRTS) (K38 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/rfa-hl-27-010-limited-competition-stimulating-access-to-research-in/), closes October 13, 2028
- [CCRP Initiative: Promoting a Basic Understanding of Chemical Threats to Skin (R01 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/par-27-075-ccrp-initiative-promoting-a-basic-understanding-of-chemical/), closes November 5, 2028
- [Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)](https://welltoldgrants.com/grants/pa-26-001-administrative-supplements-to-existing-nih-grants-and/), closes November 30, 2028
- [SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Optional)](https://welltoldgrants.com/grants/par-27-098-sbir-sttr-commercialization-readiness-pilot-crp-program/), closes April 5, 2029
- [NIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough Award (Parent [R44] Clinical Trial Optional)](https://welltoldgrants.com/grants/pa-27-101-nih-small-business-innovation-research-sbir-phase-iib/), closes April 5, 2029
- [Predoctoral to Postdoctoral Transition Award (Parent F99/K00 - Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/pa-27-037-predoctoral-to-postdoctoral-transition-award-parent-f99-k00/), closes April 8, 2029
- [NIH Research Education Program - Research Experiences (Parent R25 - Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/pa-27-036-nih-research-education-program-research-experiences-parent/), closes May 5, 2029
- [NIH Research Educational Program - Mentoring Activities & Networks (Parent R25/UE5 - Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/pa-27-035-nih-research-educational-program-mentoring-activities/), closes May 5, 2029
- [NIH Collaborative International Research Project (Parent PF5 Clinical Trial Optional)](https://welltoldgrants.com/grants/pa-26-002-nih-collaborative-international-research-project-parent-pf5/), closes May 7, 2029
- [NIH Science Education Partnership Award (SEPA) (R25 - Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/par-27-077-nih-science-education-partnership-award-sepa-r25-clinical/), closes May 25, 2029
- [NIAID Resource-Related Research Projects (R24 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/par-27-083-niaid-resource-related-research-projects-r24-clinical-trial/), closes May 25, 2029
- [NIH Research Education Program - Courses, Curriculum & Methods (Parent R25 - Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/pa-27-034-nih-research-education-program-courses-curriculum-methods/), closes May 25, 2029
- [NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/par-27-082-niaid-investigator-initiated-program-project-applications/), closes May 25, 2029
- [Centers for AIDS Research (CFAR) and Developmental Centers for AIDS Research (D-CFAR) (P30 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/par-28-090-centers-for-aids-research-cfar-and-developmental-centers/), closes May 25, 2029
- [NIH Research Program Projects (Parent P01 Clinical Trial Optional)](https://welltoldgrants.com/grants/pa-27-061-nih-research-program-projects-parent-p01-clinical-trial/), closes May 25, 2029
- [Implementation Science to Advance HIV Prevention, Treatment, and Care (R61/R33 Clinical Trial Optional)](https://welltoldgrants.com/grants/rfa-ai-27-018-implementation-science-to-advance-hiv-prevention-treatment/), closes June 20, 2029
- [NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required)](https://welltoldgrants.com/grants/par-27-064-niaid-clinical-trial-implementation-cooperative-agreement/), closes July 5, 2029
- [Academic Career Excellence (ACE) Award (K32 Independent Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/par-27-062-academic-career-excellence-ace-award-k32-independent/), closes July 12, 2029
- [Collaborative Program Grant for Interdisciplinary Teams (RM1 Clinical Trial Optional)](https://welltoldgrants.com/grants/par-27-003-collaborative-program-grant-for-interdisciplinary-teams-rm1/), closes September 26, 2029
- [Cooperative Program for Modeling Clinical Transplantation](https://welltoldgrants.com/grants/rfa-ai-27-017-cooperative-program-for-modeling-clinical-transplantation/), closes not stated
- [HIV/AIDS Clinical Trials Network Leadership and Operations Centers](https://welltoldgrants.com/grants/rfa-ai-28-001-hiv-aids-clinical-trials-network-leadership-and-operations/), closes not stated
- [HIV/AIDS Clinical Trials Network Statistical and Data Management Centers](https://welltoldgrants.com/grants/rfa-ai-28-003-hiv-aids-clinical-trials-network-statistical-and-data/), closes not stated
- [HIV/AIDS Clinical Trials Network Laboratory Centers](https://welltoldgrants.com/grants/rfa-ai-28-002-hiv-aids-clinical-trials-network-laboratory-centers/), closes not stated
- [HIV/AIDS Clinical Trials Network Clinical Trials Units](https://welltoldgrants.com/grants/rfa-ai-28-004-hiv-aids-clinical-trials-network-clinical-trials-units/), closes not stated
- [Leveraging NAMs to understand disease triggers, discover early biomarkers and develop new classes of therapeutic strategies for Type 1 Diabetes (U01 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/rfa-dk-28-113-leveraging-nams-to-understand-disease-triggers-discover/), closes not stated
- [Asthma and Allergic Diseases Cooperative Research Centers](https://welltoldgrants.com/grants/rfa-ai-28-009-asthma-and-allergic-diseases-cooperative-research-centers/), closes not stated
- [Translational Transplantation Tolerance Cooperative Study Group](https://welltoldgrants.com/grants/rfa-ai-28-010-translational-transplantation-tolerance-cooperative-study/), closes not stated
- [Implementation and Evaluation of Databases to Examine AIDS](https://welltoldgrants.com/grants/rfa-ai-28-025-implementation-and-evaluation-of-databases-to-examine-aids/), closes not stated
- [Improved Drug Susceptibility Testing (DST) for Mycobacteria](https://welltoldgrants.com/grants/rfa-ai-28-018-improved-drug-susceptibility-testing-dst-for-mycobacteria/), closes not stated
- [Childhood Asthma in Urban Settings Clinical Research Network](https://welltoldgrants.com/grants/rfa-ai-28-007-childhood-asthma-in-urban-settings-clinical-research-network/), closes not stated
- [Clinical Data, Safety and Statistical Centers (CDSSC)](https://welltoldgrants.com/grants/rfa-ai-28-006-clinical-data-safety-and-statistical-centers-cdssc/), closes not stated
- [Immune Drivers of Autoimmune Disease](https://welltoldgrants.com/grants/rfa-ai-28-011-immune-drivers-of-autoimmune-disease/), closes not stated
- [Centers for Research on Neglected Infectious Diseases](https://welltoldgrants.com/grants/rfa-ai-28-020-centers-for-research-on-neglected-infectious-diseases/), closes not stated
- [Limited Competition: Resources and Workforce Development for the Regional Biocontainment Laboratories](https://welltoldgrants.com/grants/rfa-ai-28-013-limited-competition-resources-and-workforce-development-for/), closes not stated
- [Clinical Trials in Organ Transplantation in Children and Adults](https://welltoldgrants.com/grants/rfa-ai-28-008-clinical-trials-in-organ-transplantation-in-children-and/), closes not stated
- [The Role of the Innate Immune System in the Pathogenesis of Type 1 Diabetes](https://welltoldgrants.com/grants/rfa-ai-28-029-the-role-of-the-innate-immune-system-in/), closes not stated
- [Partnerships for Advancing Development of Diagnostics for Infectious Diseases](https://welltoldgrants.com/grants/rfa-ai-28-017-partnerships-for-advancing-development-of-diagnostics-for/), closes not stated
- [LeverAging StraTegies to Maximize ImpLementation and Effectiveness for HIV (LAST MILE)](https://welltoldgrants.com/grants/rfa-ai-28-015-leveraging-strategies-to-maximize-implementation-and/), closes not stated